enGene Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP is investigating potential claims on behalf of investors of enGene Therapeutics Inc. (NASDAQ:ENGN). The investigation focuses on enGene’s executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased enGene securities?If you purchased enGene securities and suffered losses […]
Read More